N-methyl-2-(o-tolyl)ethan-1-amine

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: N-methyl-2-(o-tolyl)ethan-1-amine
• 英文别名: N-[2-(2-Methylphenyl)ethyl]-N-methylamine；N-methyl-2-(2-methylphenyl)ethanamine
• 化学式: C₁₀H₁₅N
• mdl: MFCD10687872
• 分子量: 149.236
• InChiKey: JOFBJXRAJMVOGU-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.6
• 重原子数：
  11
• 可旋转键数：
  3
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.4
• 拓扑面积：
  12
• 氢给体数：
  1
• 氢受体数：
  1

反应信息

• 作为反应物：
  描述：

  N-methyl-2-(o-tolyl)ethan-1-amine 在 2,4,6-三甲基吡啶 、 1H-咪唑-1-磺酰叠氮 、 bis{rhodium[3,3'-(1,3-phenylene)bis(2,2-dimethylpropanoic acid)]} 、 1,8-二氮杂双环[5.4.0]十一碳-7-烯 作用下， 以 四氢呋喃 、 二氯甲烷 、 1,2-二氯乙烷 、 乙腈 为溶剂， 反应 24.0h， 生成
  参考文献：
  名称：

  α-Diazo-β-ketonitriles: Uniquely Reactive Substrates for Arene and Alkene Cyclopropanation

  摘要：

  An investigation of the intramolecular cyclopropanation reactions of alpha-diazo-beta-ketonitriles is reported. These studies reveal that alpha-diazo-beta-ketonitriles exhibit unique reactivity in their ability to undergo arene cyclopropanation reactions; other similar acceptor acceptor-substituted diazo substrates instead produce mixtures of C-H insertion and dimerization products. alpha-Diazo-beta-ketonitriles also undergo highly efficient intramolecular cyclopropanation of tri- and tetrasubstituted alkenes. In addition, the alpha-cyano-alpha-ketocyclopropane products are demonstrated to serve as substrates for S(N)2, S(N)2', and aldehyde cycloaddition reactions.

  DOI：

  10.1021/ja401610p
• 作为产物：
  描述：

  邻甲基苯乙酰氯 在 硼烷四氢呋喃络合物 作用下， 以 四氢呋喃 、 水 、 甲苯 为溶剂， 反应 4.5h， 生成 N-methyl-2-(o-tolyl)ethan-1-amine
  参考文献：
  名称：

  α-Diazo-β-ketonitriles: Uniquely Reactive Substrates for Arene and Alkene Cyclopropanation

  摘要：

  An investigation of the intramolecular cyclopropanation reactions of alpha-diazo-beta-ketonitriles is reported. These studies reveal that alpha-diazo-beta-ketonitriles exhibit unique reactivity in their ability to undergo arene cyclopropanation reactions; other similar acceptor acceptor-substituted diazo substrates instead produce mixtures of C-H insertion and dimerization products. alpha-Diazo-beta-ketonitriles also undergo highly efficient intramolecular cyclopropanation of tri- and tetrasubstituted alkenes. In addition, the alpha-cyano-alpha-ketocyclopropane products are demonstrated to serve as substrates for S(N)2, S(N)2', and aldehyde cycloaddition reactions.

  DOI：

  10.1021/ja401610p

文献信息

• THERAPEUTIC AGENT FOR CEREBRAL INFARCTION
  申请人：Nakao Akira

  公开号：US20120196824A1

  公开（公告）日：2012-08-02

  The invention provides a therapeutic drug for ischemic stroke. The therapeutic drug has the formula (I) wherein each symbol is as defined herein, or a pharmacologically acceptable salt thereof, or a solvate thereof, as an active ingredient.

  这项发明提供了一种用于缺血性中风的治疗药物。该治疗药物具有如下式（I）的化学式，其中每个符号如本文所定义，或其药理学上可接受的盐，或其溶剂化物，作为活性成分。
• Modulators of Cystic Fibrosis Transmembrane Conductance Regulator
  申请人：VERTEX PHARMACEUTICALS INCORPORATED

  公开号：US20160095858A1

  公开（公告）日：2016-04-07

  The present invention features a compound of formula I: or a pharmaceutically acceptable salt thereof, where R 1 , R 2 , R 3 , W, X, Y, Z, n, o, p, and q are defined herein, for the treatment of CFTR mediated diseases, such as cystic fibrosis. The present invention also features pharmaceutical compositions, method of treating, and kits thereof.

  本发明涉及一种具有以下化学式I的化合物： 或其药用可接受的盐，其中R 1 ，R 2 ，R 3 ，W，X，Y，Z，n，o，p和q在此处定义，用于治疗CFTR介导的疾病，如囊性纤维化。本发明还涉及药物组合物、治疗方法和相关工具包。
• [EN] 2,4-DIHYDROXY-NICOTINAMIDES AS APJ AGONISTS<br/>[FR] 2,4-DIHYDROXY-NICOTINAMIDES UTILISÉS EN TANT QU'AGONISTES D'APJ
  申请人：BRISTOL MYERS SQUIBB CO

  公开号：WO2017066402A1

  公开（公告）日：2017-04-20

  The present invention provides compounds of Formula (I): wherein all variables are as defined in the specification, and compositions comprising any of such novel compounds. These compounds are APJ agonists which may be used as medicaments.

  本发明提供了式（I）的化合物：其中所有变量如规范中所定义，并包括任何此类新化合物的组合物。这些化合物是APJ激动剂，可用作药物。
• Enantioselective Ring-Closing C–H Amination of Urea Derivatives
  作者：Zijun Zhou、Yuqi Tan、Tatsuya Yamahira、Sergei Ivlev、Xiulan Xie、Radostan Riedel、Marcel Hemming、Masanari Kimura、Eric Meggers

  DOI：10.1016/j.chempr.2020.05.017

  日期：2020.8

  An enantioselective intramolecular C(sp3)–H amination of N-benzoyloxyurea by using a chiral-at-metal ruthenium catalyst is reported, providing chiral 2-imidazolidinones in yields of up to 99% and with up to 99% ee. Catalyst loadings down to 0.05 mol % are feasible. Control experiments support a stepwise nitrene insertion mechanism through hydrogen atom transfer of a ruthenium nitrenoid intermediate

  据报道，通过使用手性金属钌催化剂进行N-苯甲酰氧基脲的对映选择性分子内C（sp 3）-H胺化反应，可提供手性2-咪唑烷酮类，产率高达99％，ee高达99％。降低至0.05mol％的催化剂负载是可行的。对照实验通过钌氮烯类中间体的氢原子转移然后进行自由基重组来支持逐步的氮烯插入机理。手性2-咪唑啉酮在生物活性化合物中普遍存在，并且可以一步转化为手性邻位二胺。证明了该新方法的合成价值用于合成药物左旋咪唑和右旋咪唑，双吲哚生物碱托普汀D和海绵蛋白A的中间体，以及手性有机催化剂。
• [EN] BISARYL HETEROCYCLES AS NRF2 ACTI<br/>[FR] HÉTÉROCYCLES BISARYLE EN TANT QUE NRF2 ACTI
  申请人：GLAXOSMITHKLINE IP DEV LTD

  公开号：WO2018109643A1

  公开（公告）日：2018-06-21

  The present invention relates to bisaryl heterocycle compounds, methods of making them, pharmaceutical compositions containing them and their use as NRF2 activators. In particular, the invention relates to bisaryl heterocycles of Formula (I),

  本发明涉及双芳基杂环化合物，制备方法，包含它们的药物组合物以及它们作为NRF2激活剂的用途。具体而言，该发明涉及式（I）的双芳基杂环化合物。